MX2017007196A - Fibroblastos de embrion de pollo inmortalizados. - Google Patents

Fibroblastos de embrion de pollo inmortalizados.

Info

Publication number
MX2017007196A
MX2017007196A MX2017007196A MX2017007196A MX2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A MX 2017007196 A MX2017007196 A MX 2017007196A
Authority
MX
Mexico
Prior art keywords
chicken embryo
embryo fibroblasts
immortalised
cells
immortalised chicken
Prior art date
Application number
MX2017007196A
Other languages
English (en)
Other versions
MX373660B (es
Inventor
Jaap Kool
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2017007196A publication Critical patent/MX2017007196A/es
Publication of MX373660B publication Critical patent/MX373660B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C12N7/08—Inactivation or attenuation by serial passage of virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C12N7/025—Packaging cell lines, e.g. transcomplementing cell lines, for production of virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell
    • C12N2330/51—Specially adapted vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se relaciona con fibroblastos de embrión de pollo inmortalizados, con cultivos celulares que comprenden tales células inmortalizadas, con vacunas que comprenden tales células, con métodos para la propagación de virus aviares en tales células y con métodos para la preparación de tales células y tales vacunas.
MX2017007196A 2014-12-04 2015-12-03 Fibroblastos de embrion de pollo inmortalizados. MX373660B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14196345 2014-12-04
PCT/EP2015/078457 WO2016087560A1 (en) 2014-12-04 2015-12-03 Immortalised chicken embryo fibroblasts

Publications (2)

Publication Number Publication Date
MX2017007196A true MX2017007196A (es) 2017-08-28
MX373660B MX373660B (es) 2020-03-31

Family

ID=52003640

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017007196A MX373660B (es) 2014-12-04 2015-12-03 Fibroblastos de embrion de pollo inmortalizados.

Country Status (10)

Country Link
US (1) US10428316B2 (es)
EP (1) EP3227433B1 (es)
JP (1) JP6546659B2 (es)
CN (1) CN107002044B (es)
BR (1) BR112017011582A2 (es)
ES (1) ES2700147T3 (es)
MX (1) MX373660B (es)
PL (1) PL3227433T3 (es)
RU (1) RU2694318C2 (es)
WO (1) WO2016087560A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
WO2018093903A1 (en) * 2016-11-17 2018-05-24 Regents Of The University Of Minnesota Immortalized cell lines and methods of use
CN107099513B (zh) * 2017-06-22 2020-07-14 北京邦卓生物科技有限公司 一种共表达ndv hn和ibdv vp2基因的hvt的构建及其应用
US11479792B2 (en) * 2017-07-13 2022-10-25 Upside Foods, Inc. Compositions and methods for increasing the efficiency of cell cultures used for food production
BR112020012162A2 (pt) 2017-12-20 2020-11-24 Intervet International B.V. diluente aprimorado para vacina contra alfa-herpesvírus associado à célula
CN114828882A (zh) 2019-12-20 2022-07-29 英特维特国际股份有限公司 多价hvt载体疫苗
US12440556B2 (en) * 2020-06-15 2025-10-14 Zoetis Services Llc Genetically modified cell line for production of Marek's disease virus vaccine and methods of making and using the same
CN116528893A (zh) 2020-09-07 2023-08-01 英特维特国际股份有限公司 用于ha抗体阳性靶标的ha茎疫苗
JP2024501943A (ja) 2020-12-24 2024-01-17 インターベット インターナショナル ベー． フェー． 多価ｈｖｔベクターワクチン
CN112574946B (zh) * 2020-12-28 2023-12-12 中国科学院昆明动物研究所 一种原代分离培养土狗多个组织来源的成纤维细胞及其永生化的构建方法
US20250009868A1 (en) 2021-07-13 2025-01-09 Intervet Inc. Overcoming antibody-interference in avians
CN114107171B (zh) * 2021-11-12 2022-12-27 广东省华晟生物技术有限公司 鹅视网膜上皮细胞系及其构建方法与应用
CN114908053A (zh) * 2022-04-24 2022-08-16 上海交通大学 孔雀成纤维永生化细胞系的制备方法及其在病毒扩增中的应用
US20250352642A1 (en) 2022-05-05 2025-11-20 Intervet Inc. New multivalent hvt vector vaccine
CN114891722A (zh) * 2022-05-13 2022-08-12 广东省农业科学院动物卫生研究所 禽肠道上皮细胞及其制备方法和应用
WO2023240152A1 (en) 2022-06-07 2023-12-14 Upside Foods, Inc. Engineering cell lines capable of proliferation in growth factor free media formulations
CN114958769B (zh) * 2022-06-09 2024-03-12 浙江大学 一种永生化羊前体脂肪细胞系、及其制备方法和应用
JP2023181738A (ja) * 2022-06-13 2023-12-25 株式会社東芝 ポリペプチド、外来遺伝子発現方法、導入キャリア及びキット
CN121022766B (zh) * 2025-10-31 2026-03-03 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 复制受限性重组猫疱疹病毒及其构建方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749022B1 (fr) * 1996-05-23 2001-06-01 Rhone Merieux Cellules aviaires immortelles
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
JP2004504024A (ja) * 2000-07-18 2004-02-12 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム 前脂肪細胞系
EP1528101A1 (en) * 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
US7629168B2 (en) * 2003-11-10 2009-12-08 Noriaki Tanaka Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof
CN1926233A (zh) 2004-03-31 2007-03-07 财团法人东京都医学研究机构 可逆性无限增殖化哺乳类肝细胞及其用途
CN101365789A (zh) * 2006-01-05 2009-02-11 特兰斯吉恩股份有限公司 鸟类端粒酶反转录酶
AU2007204024B2 (en) * 2006-01-05 2012-01-19 Transgene S.A. Avian telomerase reverse transcriptase
JP5016241B2 (ja) 2006-03-09 2012-09-05 中外製薬株式会社 不死化ヒトメサンギウム細胞
CA2691868C (en) * 2007-07-03 2016-12-20 Transgene S.A. Immortalized avian cell lines
CN102105488A (zh) * 2008-07-18 2011-06-22 朱志强 真核细胞的长期培养方法及其应用
AU2010206374B2 (en) * 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
EP2248889A1 (en) * 2009-05-06 2010-11-10 Sanofi-Aventis Reversibly immortalized cells as well as methods relating hetero
WO2012170995A2 (en) * 2011-06-10 2012-12-13 University Of Georgia Research Foundation, Inc. Avian induced pluripotent stem cells and their use
CN102876717B (zh) * 2012-10-29 2014-06-11 东北农业大学 一种建立鸡永生化前脂肪细胞的方法
CN103695466B (zh) * 2013-12-17 2016-04-27 中国农业大学 一种诱导动物体外细胞可逆永生化的载体及其应用
US20190144831A1 (en) * 2015-12-11 2019-05-16 Intervet Inc. Immortalised chicken embryonic epithelial kidney cells

Also Published As

Publication number Publication date
CN107002044A (zh) 2017-08-01
US20180171309A1 (en) 2018-06-21
MX373660B (es) 2020-03-31
EP3227433A1 (en) 2017-10-11
WO2016087560A1 (en) 2016-06-09
PL3227433T3 (pl) 2019-01-31
JP6546659B2 (ja) 2019-07-17
RU2694318C2 (ru) 2019-07-11
CN107002044B (zh) 2020-10-30
RU2017119011A (ru) 2019-01-09
RU2017119011A3 (es) 2019-01-09
BR112017011582A2 (pt) 2018-02-27
EP3227433B1 (en) 2018-10-10
US10428316B2 (en) 2019-10-01
JP2017537624A (ja) 2017-12-21
ES2700147T3 (es) 2019-02-14

Similar Documents

Publication Publication Date Title
MX2017007196A (es) Fibroblastos de embrion de pollo inmortalizados.
EP3240551A4 (en) Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
MX2023011785A (es) Metodos y composiciones para produccion de proteina de clara de huevo.
ZA201608303B (en) Methods for harvesting mammalian cell cultures
BR112018002600A2 (pt) células para imunoterapia modificadas para direcionamento ao antígeno cd38 e para inativação do gene cd38
MA39819A (fr) Méthodes et compositions d'immunomodulation
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
DK4219687T3 (da) Fremgangsmåder til isolering, dyrkning og genmanipulering af immuncellepopulationer til adoptiv terapi
IL249828A0 (en) Limbal stem cells of cultured mammals, methods of their creation and uses thereof
MX375786B (es) Biosintesis microbiana de ergotioneina.
BR112016017806A2 (pt) células para imunoterapia engenheiradas para direcionamento de antígeno presente em ambas as células imunes e células patológicas
EA201790505A1 (ru) Соединение, нацеленое на ил-23а и фно-альфа, и его применение
EP3238411A4 (en) System and method to combine multiple reputations
EP3224349A4 (en) Method for culturing natural killer cells using t cells
MY191539A (en) Streptococcal vaccine
DK3132023T3 (da) Metode til at forberede celler til 3D-vævskultur
MA39990A (fr) Induction de régénération cardiaque par micro-arn
ITUB20151992A1 (it) Piastra multi-pozzetto per colture cellulari
IL251616B (en) Methods and compounds for the treatment and prevention of muscle mass loss
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
IN2014MU00455A (es)
MX2015016765A (es) Celulas aviares para la produccion mejorada de virus.
IT201700026465A1 (it) Supplementi per colture cellulari
EP3183333A4 (en) Primary mammalian cell culture systems and methods
MX382334B (es) Métodos para producir glucoproteínas recombinantes con glucosilación modificada.

Legal Events

Date Code Title Description
FG Grant or registration